Dr Ian Irving brings strong leadership to the board having performed senior clinical and administrative roles in the cancer care sector and is currently Icon Group’s Medical Director. Ian spent several years in haematology practice at Icon Townsville, and during that time was also the Director of Haematology and Bone Marrow Transplantation at the Townsville Hospital and the Clinical Director of the Institute of Cancer from 2006 – 2013. He was also responsible for consolidating and expanding tertiary level cancer care in North Queensland. He continues his practice at Icon Wesley and clinics at Icon Mackay.
Further to his broad haematological knowledge, Ian has a special clinical interest in lymphoma, myelodysplasia and myeloproliferative disorders. He has sat on national and international committees and advisory boards, focusing on haematological disorders such as chronic myeloid leukaemia, myelofibrosis, myelodysplasia, lymphoma and bone marrow transplantation. Ian is a strong advocate for clinical trial research, participating in phase I, II and III multi-centre clinical trials.